Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vittorio Limongelli

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Biochemical Pharmacology|April 25, 2020
Identification of cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1Michele Biagioli, Adriana Carino, Silvia Marchianò, et al.
ACS Medicinal Chemistry Letters|April 19, 2019
Investigation around the Oxadiazole Core in the Discovery of a New Chemotype of Potent and Selective FXR AntagonistsCarmen Festa, Claudia Finamore, Silvia Marchianò, et al.
Journal of Medicinal Chemistry|February 26, 2010
Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell modelsElisa Nuti, Francesca Casalini, Stanislava I Avramova, et al.
Frontiers in Pharmacology|April 21, 2017
Targeting Bile Acid Receptors: Discovery of a Potent and Selective Farnesoid X Receptor Agonist as a New Lead in the Pharmacological Approach to Liver DiseasesCarmen Festa, Simona De Marino, Adriana Carino, et al.
Marine Drugs|May 30, 2014
Marine and semi-synthetic hydroxysteroids as new scaffolds for pregnane X receptor modulationValentina Sepe, Francesco Saverio Di Leva, Claudio D'Amore, et al.
Frontiers in Pharmacology|May 13, 2022
Discovery of a Potent and Orally Active Dual GPBAR1/CysLT<sub>1</sub>R Modulator for the Treatment of Metabolic Fatty Liver DiseaseStefano Fiorucci, Pasquale Rapacciuolo, Bianca Fiorillo, et al.
ACS Omega|December 4, 2023
Correction to "Discovery of a Novel Class of Dual GPBAR1 Agonists-RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders"Bianca Fiorillo, Rosalinda Roselli, Claudia Finamore, et al.
Journal of Medicinal Chemistry|July 22, 2008
Ethyl 8-fluoro-6-(3-nitrophenyl)-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate as novel, highly potent, and safe antianxiety agentMaurizio Anzini, Carlo Braile, Salvatore Valenti, et al.
ACS Omega|February 23, 2023
Discovery of a Novel Class of Dual GPBAR1 Agonists-RORγt Inverse Agonists for the Treatment of IL-17-Mediated DisordersBianca Fiorillo, Rosalinda Roselli, Claudia Finamore, et al.
Frontiers in Chemistry|July 18, 2020
Binding of the Anti-FIV Peptide C8 to Differently Charged Membrane Models: From First Docking to Membrane TubulationDaniele Di Marino, Agostino Bruno, Manuela Grimaldi, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Biochemical Pharmacology|April 25, 2020
Identification of cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1Michele Biagioli, Adriana Carino, Silvia Marchianò, et al.
ACS Medicinal Chemistry Letters|April 19, 2019
Investigation around the Oxadiazole Core in the Discovery of a New Chemotype of Potent and Selective FXR AntagonistsCarmen Festa, Claudia Finamore, Silvia Marchianò, et al.
Journal of Medicinal Chemistry|February 26, 2010
Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell modelsElisa Nuti, Francesca Casalini, Stanislava I Avramova, et al.
Frontiers in Pharmacology|April 21, 2017
Targeting Bile Acid Receptors: Discovery of a Potent and Selective Farnesoid X Receptor Agonist as a New Lead in the Pharmacological Approach to Liver DiseasesCarmen Festa, Simona De Marino, Adriana Carino, et al.
Marine Drugs|May 30, 2014
Marine and semi-synthetic hydroxysteroids as new scaffolds for pregnane X receptor modulationValentina Sepe, Francesco Saverio Di Leva, Claudio D'Amore, et al.
Frontiers in Pharmacology|May 13, 2022
Discovery of a Potent and Orally Active Dual GPBAR1/CysLT<sub>1</sub>R Modulator for the Treatment of Metabolic Fatty Liver DiseaseStefano Fiorucci, Pasquale Rapacciuolo, Bianca Fiorillo, et al.
ACS Omega|December 4, 2023
Correction to "Discovery of a Novel Class of Dual GPBAR1 Agonists-RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders"Bianca Fiorillo, Rosalinda Roselli, Claudia Finamore, et al.
Journal of Medicinal Chemistry|July 22, 2008
Ethyl 8-fluoro-6-(3-nitrophenyl)-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate as novel, highly potent, and safe antianxiety agentMaurizio Anzini, Carlo Braile, Salvatore Valenti, et al.
ACS Omega|February 23, 2023
Discovery of a Novel Class of Dual GPBAR1 Agonists-RORγt Inverse Agonists for the Treatment of IL-17-Mediated DisordersBianca Fiorillo, Rosalinda Roselli, Claudia Finamore, et al.
Frontiers in Chemistry|July 18, 2020
Binding of the Anti-FIV Peptide C8 to Differently Charged Membrane Models: From First Docking to Membrane TubulationDaniele Di Marino, Agostino Bruno, Manuela Grimaldi, et al.
Pageof 9